Related Experiment Video

Updated: Jun 12, 2026

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

Complexity analysis of spontaneous brain activity in Alzheimer disease and mild cognitive impairment: an MEG study

Alberto Fernández1, Roberto Hornero, Carlos Gómez

  • 1Centro de Magnetoencefalografía Dr. Pérez-Modrego, Facultad de Medicina, Pabellón, Universidad Complutense de Madrid, Madrid, Spain. aferlucas@med.ucm.es

Alzheimer Disease and Associated Disorders
|May 28, 2010
PubMed

Insights

Mild cognitive impairment (MCI) patients show distinct brain complexity patterns compared to Alzheimer's disease (AD) patients and healthy controls. This difference may indicate a compensatory mechanism before dementia fully develops.

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Cognitive Science

Background:

  • Alzheimer's disease (AD) is associated with reduced brain activity complexity and connectivity.
  • Understanding brain activity patterns in mild cognitive impairment (MCI) is crucial for early detection and intervention.
  • Nonlinear analyses offer insights into complex brain dynamics.

Purpose of the Study:

  • To define the complexity patterns of brain activity in patients with mild cognitive impairment (MCI).
  • To differentiate MCI patients from Alzheimer's disease (AD) patients and healthy controls using brain complexity measures.
  • To explore the relationship between aging, brain complexity, and cognitive status.

Main Methods:

  • Magnetoencephalography (MEG) recordings were obtained from 18 AD patients, 18 MCI patients, and 18 healthy controls.
  • Resting-state brain activity was analyzed using Lempel-Ziv complexity (LZC) to quantify signal complexity.
  • Statistical analyses were performed to compare LZC values between groups and explore correlations with age.

Main Results:

  • MCI patients displayed Lempel-Ziv complexity (LZC) scores intermediate between AD patients and healthy controls.
  • A combination of age and posterior LZC scores achieved 94.4% accuracy in discriminating AD from MCI.
  • Anterior LZC scores differentiated MCI from controls in individuals under 75, with older MCI patients showing higher complexity than controls, suggesting a compensatory mechanism.

Conclusions:

  • MCI patients exhibit unique brain complexity patterns that differ from both AD patients and healthy controls.
  • Age-related complexity reduction in MCI deviates from the typical pattern observed in healthy aging and AD.
  • The distinct complexity-aging relationship in MCI may represent a compensatory mechanism preceding the onset of full dementia.

More Related Videos

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease09:38

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...